BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao L, Zhao W, Hou Y, Wen C, Wang J, Wu P, Guo Z. An Overview of Managements in Meningiomas. Front Oncol 2020;10:1523. [PMID: 32974188 DOI: 10.3389/fonc.2020.01523] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Spille DC, Lohmann S, Schwake M, Spille J, Alsofy SZ, Stummer W, Brokinkel B, Schipmann S. Can Currently Suggested Quality Indicators Be Transferred to Meningioma Surgery?-A Single-Center Pilot Study. J Neurol Surg A Cent Eur Neurosurg 2022. [PMID: 35901814 DOI: 10.1055/a-1911-8678] [Reference Citation Analysis]
2 Elbeheiry AA, Fayed AA, Alkassas AH, Emara DM. Can magnetic resonance imaging predict preoperative consistency and vascularity of intracranial meningioma? Egypt J Radiol Nucl Med 2022;53:31. [DOI: 10.1186/s43055-022-00706-2] [Reference Citation Analysis]
3 Chotai S, Tang AR, Gupta R, Guidry BS, Mcdermott JR, Grisham CJ, Morone PJ, Thompson RC, Chambless LB. Matched case–control analysis of outcomes following surgical resection of incidental meningioma. J Neurooncol 2022. [DOI: 10.1007/s11060-022-04167-5] [Reference Citation Analysis]
4 Akhtar K, Sinha D, Adil M, Aprajita. Meningioma – A spectrum of varied case presentations: A case series. IJN 2022;8:212-216. [DOI: 10.18231/j.ijn.2022.043] [Reference Citation Analysis]
5 Kohl J, König RE, Kraus A, Mawrin C, Paukisch H, Stein K, Rashidi A, Luchtmann M, Sandalcioglu IE, Lilla N. Angiosarcoma on Top of a Meningioma Mimicking a Transosseous Meningioma: an Interdisciplinary Point of View. J Neurol Surg A Cent Eur Neurosurg 2022. [DOI: 10.1055/s-0042-1751262] [Reference Citation Analysis]
6 Abdelrahman A, Negroni C, Sahm F, Adams CL, Urbanic-Purkart T, Khalil M, Vergura R, Morelli C, Hanemann CO. miR-497 and 219 in blood aid meningioma classification. J Neurooncol 2022. [PMID: 36076132 DOI: 10.1007/s11060-022-04126-0] [Reference Citation Analysis]
7 Fu X, Li J, Li X, Tan Y, Zhao M, Zhang S, Wu X, Xu J, Wang F. M2-Macrophage-Derived Exosomes Promote Meningioma Progression through TGF-β Signaling Pathway. Journal of Immunology Research 2022;2022:1-20. [DOI: 10.1155/2022/8326591] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Esteban Garcia-robledo J, Ordóñez-reyes C, Ruiz-patiño A, Muñoz Á, Arrieta O, Jiménez E, Hakim F, Gómez D, Fernando Ramón J, F. Cardona A. High Grade Meningiomas: Current Therapy Based on Tumor Biology. Brain Tumors 2022. [DOI: 10.5772/intechopen.100432] [Reference Citation Analysis]
9 Patel B, Desai R, Pugazenthi S, Butt OH, Huang J, Kim AH. Identification and Management of Aggressive Meningiomas. Front Oncol 2022;12:851758. [PMID: 35402234 DOI: 10.3389/fonc.2022.851758] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Mallik J, Narayan S, Choudhary N. Multiple Intracranial Meningiomas in Absence of Neurofibromatosis Type 2: A Case Report and Literature Review. Cureus 2022. [DOI: 10.7759/cureus.22118] [Reference Citation Analysis]
11 Tollefsen SE, Jarmund AH, Ytterhus B, Salvesen Ø, Mjønes P, Torp SH. Somatostatin Receptors in Human Meningiomas-Clinicopathological Aspects. Cancers (Basel) 2021;13:5704. [PMID: 34830858 DOI: 10.3390/cancers13225704] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Gareev I, Beylerli O, Liang Y, Xiang H, Liu C, Xu X, Yuan C, Ahmad A, Yang G. The Role of MicroRNAs in Therapeutic Resistance of Malignant Primary Brain Tumors. Front Cell Dev Biol 2021;9:740303. [PMID: 34692698 DOI: 10.3389/fcell.2021.740303] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
13 Chen X, Tian F, Lun P, Feng Y. Curcumin Inhibits HGF-Induced EMT by Regulating c-MET-Dependent PI3K/Akt/mTOR Signaling Pathways in Meningioma. Evid Based Complement Alternat Med 2021;2021:5574555. [PMID: 34408780 DOI: 10.1155/2021/5574555] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Terabe M, Wu J. Rethinking Immunotherapy in Meningiomas. Neuro Oncol 2021:noab168. [PMID: 34244788 DOI: 10.1093/neuonc/noab168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Randhawa KS, Choi CB, Shah AD, Parray A, Fang CH, Liu JK, Baredes S, Eloy JA. Impact of Diabetes Mellitus on Adverse Outcomes After Meningioma Surgery. World Neurosurg 2021;152:e429-35. [PMID: 34062298 DOI: 10.1016/j.wneu.2021.05.101] [Reference Citation Analysis]
16 Ius T, Tel A, Minniti G, Somma T, Solari D, Longhi M, De Bonis P, Scerrati A, Caccese M, Barresi V, Fiorentino A, Gorgoglione L, Lombardi G, Robiony M. Advances in Multidisciplinary Management of Skull Base Meningiomas. Cancers (Basel) 2021;13:2664. [PMID: 34071391 DOI: 10.3390/cancers13112664] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Ogasawara C, Philbrick BD, Adamson DC. Meningioma: A Review of Epidemiology, Pathology, Diagnosis, Treatment, and Future Directions. Biomedicines 2021;9:319. [PMID: 33801089 DOI: 10.3390/biomedicines9030319] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]